FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Resources - All Kinds, Realm US, Authority Hl7

19,360 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

 

Start Prev Rows 7600 - 7800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateUsage #
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.662.jsonLong term preventive treatment for cluster headacheactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.663.jsonMigraine diagnosis (ICD)active2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.664.jsonPrescribable NSAIDs and Acute Migraine Attack Medicationactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.103.jsonAbnormal Presentationactive2023-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.105.jsonAbnormal Presentationactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.130.jsonRespiratory Rateactive2023-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.15.jsonIntravenous Thrombolytic tPA Therapyactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.16.jsonIntraarterial Thrombolytic tPA Therapyactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.163.jsonSystolic Blood Pressureactive2023-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.171.jsonAbnormal Presentationactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.173.jsonDelivery of Singletonactive2021-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.21.jsonIntravenous or Intraarterial Thrombolytic tPA Therapyactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.26.jsonEstimated Gestational Age at Deliveryactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.27.jsonCornual Ectopic Pregnancyactive2021-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.38.jsonGeneral Or Neuraxial Anesthesiaactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.39.jsonLow Dose Unfractionated Heparin for VTE Prophylaxisactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.41.jsonGlycoprotein IIb IIIa Inhibitorsactive2023-011
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.55.jsonOxytocinactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.56.jsonDinoprostoneactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.58.jsonDelivery Proceduresactive2021-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.59.jsonDelivery Proceduresactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.67.jsonPCIactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.68.jsonEndotracheal Intubationactive2018-031
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.69.jsonEndotracheal Intubationactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.98.jsonDelivery of Singletonactive2021-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.99.jsonDelivery of Singletonactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.225.jsonOpioid Medication Assisted Treatment (MAT) SNOMEDactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.241.jsonSchedule II, III and IV Opioid Medicationsactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.242.jsonOpioid Use Disorderactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.243.jsonOpioid Use Disorderactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.265.jsonInpatient, Emergency, and Observation Locationsactive2022-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.269.jsonMedications for Opioid Use Disorder (MOUD)active2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.274.jsonNHSN Inpatient Encounter Class Codesactive2024-04
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.277.jsonEmergency Department Locationactive2024-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.278.jsonEmergency Department Treatment Locationactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.283.jsonEmergency Department Locationactive2024-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.284.jsonEmergency Department Locationactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.285.jsonMental Health Diagnosis without Substance Use Disordersactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.286.jsonDecision to Transferactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.35.jsonHealthcare Agent or Proxy Choicesactive2022-104
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.10.jsonBreastfeedingactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.100.jsonFamilial Hypercholesterolemiaactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.102.jsonRhabdomyolysisactive2017-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.107.jsonLow Intensity Statin Therapyactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.12.jsonLiver Diseaseactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.13.jsonRhabdomyolysisactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.19.jsonAtherosclerosis and Peripheral Arterial Diseaseactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.20.jsonAtherosclerosis and Peripheral Arterial Diseaseactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.21.jsonAtherosclerosis and Peripheral Arterial Diseaseactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.22.jsonLiver Disease ICD9active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.37.jsonStable and Unstable Anginaactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.39.jsonCerebrovascular Disease Stroke or TIAactive2023-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.41.jsonIschemic Heart Disease or Related Diagnosesactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.42.jsonLiver Diseaseactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.43.jsonLiver Diseaseactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.44.jsonCerebrovascular Disease Stroke or TIAactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.46.jsonIschemic Heart Disease or Related Diagnosesactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.47.jsonStable and Unstable Anginaactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.501.jsonOverweight or Obeseactive2025-011
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.502.jsonOverweight or Obeseactive2018-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.512.jsonElevated Blood Pressure Readingactive2019-031
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.513.jsonElevated Blood Pressure Readingactive2020-031
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.514.jsonFinding of Elevated Blood Pressure or Hypertensionactive2019-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.515.jsonBariatric Proceduresactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.517.jsonAge related macular degeneration intermediate dryactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.518.jsonOphthalmologist visitactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.519.jsonPosterior vitreous detachment (PVD)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.521.jsonOphthalmoscopic examactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.523.jsonOpthalmoscopic exams with Scleral Depressionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.525.jsonReferral (ophthalmology)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.526.jsonRetina Ultrasoundactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.527.jsonRetina visualization inadequateactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.528.jsonRefusal or Noncompliance with treatmentactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.529.jsonVitreous hemorrhageactive2024-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.530.jsonVitreous hemorrhageactive2024-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.536.jsonMacula examinationactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.539.jsonFluorescein angiographyactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.541.jsonOptical coherence tomography (OCT)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.542.jsonIntravitreal injectionactive2024-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.543.jsonBevacizumab injectionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.544.jsonRanibizumab injectionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.545.jsonAflibercept injectionactive2024-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.552.jsonUveitisactive2024-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.553.jsonUveitisactive2024-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.554.jsonPost Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edemaactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.555.jsonMacular edemaactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.556.jsonCorticosteroids for Injectionactive2024-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.557.jsonCorticosteroids for Injectionactive2024-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.560.jsonTonometryactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.561.jsonIntraocular pressureactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.571.jsonRetinal Vein Occlusion Related Macular Edemaactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.576.jsonVitreous hemorrhageactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.580.jsonIntravitreal and Periocular Injectionsactive2020-031
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.581.jsonIntravitreal and Periocular Injectionsactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.582.jsonCorticosteroids for Injectionactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.583.jsonEndophthalmitis in the Right Eyeactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.584.jsonEndophthalmitis in the Left Eyeactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.585.jsonPanophthalmitis in the Right Eyeactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.586.jsonPanophthalmitis in the Left Eyeactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.587.jsonLost to follow upactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.588.jsonUveitisactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.610.jsonScleral depressed examactive2020-031
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.611.json3 Mirror Goldmann examactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.612.jsonScleral depressed examactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.615.jsonPhysical Disabilityactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.616.jsonFinancial difficultyactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.617.jsonVitreous exam findingsactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.619.jsonScleral depressed examactive2020-031
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.629.jsonPost operative follow upactive2020-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.67.jsonBreastfeedingactive2017-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.69.jsonStable and Unstable Anginaactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.70.jsonIschemic Heart Disease or Related Diagnosesactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.71.jsonCerebrovascular Disease Stroke or TIAactive2023-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.73.jsonBreastfeedingactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.85.jsonFamilial Hypercholesterolemiaactive2023-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.89.jsonRhabdomyolysisactive2017-052
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.9.jsonOutpatient Encounters for Preventive Careactive2019-031
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.91.jsonFamilial Hypercholesterolemiaactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.93.jsonHypercholesterolemia ICD 9active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.97.jsonHigh Intensity Statin Therapyactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.98.jsonModerate Intensity Statin Therapyactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.50.jsonHIV Lab Testsactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.51.jsonIndicators of Human Immunodeficiency Virus (HIV)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.52.jsonIndicators of Human Immunodeficiency Virus (HIV)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.53.jsonIndicators of Human Immunodeficiency Virus (HIV)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.71.jsonHuman Immunodeficiency Virus (HIV) Viral Loadactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.10.jsonARBs (Angiotensin Receptor Blockers)active2024-123
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1000.jsonOIA_V2_GLP1s_RxNormsactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1001.jsonOIA_V2_PCSK9s_RxNormsactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1002.jsonOIA_RFs_Secondary_Prevention_ICD10active2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1003.jsonOIA_RFs_Secondary_Prevention_SNOMEDactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1004.jsonOIA_RFs_Secondary_Prevention_CPTactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1005.jsonOIA_RFs_Secondary_Prevention_ICD_SM_CPTactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1006.jsonOIA_Asthma_COPD_Combo_Medsactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1007.jsonOIA_Asthma_COPD_Combo_Meds_SABA_SAMAactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1008.jsonOIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICSactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1009.jsonPAE_Patient_Conditionsactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1012.jsonPAE Conditions Shortactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1016.jsonOIA_TEST_VSactive2025-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1017.jsonTriptan Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1018.jsonNSAID Allergy NDFRTactive2025-04
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1019.jsonStatin Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1021.jsonPenicillin Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1022.jsonMacrolide Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1023.jsonQuinolone Allergy NDFRTactive2025-04
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1025.jsonBeta blocker Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1026.jsonACE inhibitor Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1027.jsonARB Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1028.jsonSulfonylurea Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1030.jsonDPP4i Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1031.jsonGLP1RA Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1032.jsonBeta blocker allergy intoleranceactive2025-04
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1033.jsonSGLT2i Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1034.jsonMRA Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1036.jsonMeglitinide Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1037.jsonAlpha glucosidase inhibitor Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1038.jsonTZD Allergy NDFRTactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1041.jsonHemoglobinactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1042.jsonHematocritactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1043.jsonAnemia for Erythropoesis Simulating Agents I10active2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1044.jsonAnemia for Erythropoesis Simulating Agents SCTactive2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1045.jsonAnemia for Erythropoesis Simulating Agentsactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1046.jsonAZT Medsactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1047.jsonFerritinactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1048.jsonKnee pain I10active2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1049.jsonKnee pain SCTactive2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.105.jsonconditions_heartfailureactive2023-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1050.jsonKnee painactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1051.jsonKnee decreased ROM SCTactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1052.jsonKnee effusion I10active2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1054.jsonKnee effusionactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1055.jsonKnee crepitus SCTactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1056.jsonOIA_Antiemeticsactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1057.jsonOIA_PDE5isactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1058.jsonOIA_Vitaminsactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1059.jsonOIA_Plavixactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1061.jsonOIA_Oral_Contraceptivesactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1063.jsonOIA_Topical_Steroidsactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1064.jsonOIA_Cough_Cold_Medsactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1065.jsonAntiperspirant aluminum saltsactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1066.jsonAntiperspirant anticholinergicsactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1067.jsonAntieplieptic medicationsactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1068.jsonAntidepressant medicationsactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1069.jsonUrinary incontinence SCTactive2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1070.jsonUrinary incontinence I10active2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1071.jsonUrinary incontinenceactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1073.jsonHemifacial spasm SCTactive2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1074.jsonHemifacial spasm I10active2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1075.jsonHemifacial spasmactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1076.jsonSpasmodic dysphonia SCTactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1077.jsonPhysical therapy procedure SCTactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1078.jsonOccupational therapy SCTactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1079.jsonHyperhidrosis SCTactive2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1080.jsonHyperhidrosis I10active2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1081.jsonHyperhidrosisactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1082.jsonTic disorder I10active2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1083.jsonTic disorder SCTactive2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1084.jsonTic disorderactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1085.jsonEsophageal achalasia SCTactive2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1086.jsonEsophageal achalasia I10active2025-051